Demographic, anthropometric, functional, and metabolic characteristics
Medical information including medications was obtained from clinical databases. At baseline (pre‐) and follow‐up (post‐; within 1 week of completing the 12‐week intervention), the participants' height (baseline measurement only), body mass, waist circumference, body composition (bioelectrical impedance analysis; UM‐041, Tanita, Roxton Industries Inc., Kitchener, ON), resting heart rate (RHR) and blood pressure were measured, and a fasting blood sample was collected to obtain plasma and subsequently measure glucose concentration and glycated hemoglobin levels (HbA1c). A 6‐min walk test (6MWT) was also performed at baseline and follow‐up (Reed et al., 